Learning surgical skills for cataract removal will be a major focus of the training.
Simulation training allows the visiting eye care teams to grow their confidence in a training environment before moving on to real-life surgical procedures. The participants will hone their skills using cutting-edge ophthalmic surgical simulation training technology on the Flying Eye Hospital, which is currently at Fort Worth Alliance Airport, and additional hands-on training in the Alcon Experience Center (AEC), a state-of-the-art training facility on Alcon's nearby campus. Over a 2-week period, Orbis's clinical staff and volunteer faculty (medical experts), along with Alcon bioengineers and trainers, will share their knowledge with nearly 50 ophthalmologists, ophthalmology residents, nurses and biomedical engineers from several countries throughout the Caribbean, 1 helping them build skills to fight avoidable blindness in their communities. Accessed September 7, 2023.On August 8, Orbis International, with support from Alcon, will kick off its first in-person training project on board the Flying Eye Hospital-a fully accredited ophthalmic teaching hospital on board a plane-since the pandemic began. Wainwright 25th Annual Global Investment Conference. Rezolute to Participate in Upcoming Investor Conferences in September.
#ORBIS CLINICAL ARCHIVE#
An archive of the presentation may be accessed for 90 days on the Investors page of the Opthea website at. The presentation will available to access live by registering online. Morris will present on Wednesday, September 13 at 12:00 pm ET. Opthea Limited has also announced that Tim Morris, the company’s Chief Financial Officer will present at the conference. A replay will be archived for 90 days on the company’s website following the presentation date.
Rezolute is currently developing RZ402, an orally available plasma kallikrein inhibitor, for the treatment of diabetic macular edema. 1Īlso on September 12, 2023, Rezolute will have a company presentation by Nevan Charles Elam, Chief Executive Officer and Founder, at 2:00 pm ET. The company is focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye. On September 12, 2023, Ocular Therapeutix will be hosting one-on-one meetings with investors at this conference. Wainwright 25th Annual Global Investment Conference will be held at the Lotte New York Palace Hotel in New York City from September 11-13, 2023. Wainwright 25th Annual Global Investment Conference These conferences will highlight the current state of the companies and showcase their pipelines as each one works towards new solutions for some of the industry’s leading causes of blindness and vision loss. Ophthalmic pharmaceutical companies are slated to participate in upcoming investors conferences.
0 kommentar(er)
